Please enable JavaScript to continue using this application.

Compare $IVVD vs $WHWK | Chartloom

Compare

$IVVD vs $WHWK

Invivyd Inc · Whitehawk Therapeutics Inc

IVVD

Invivyd Inc

WHWK

Whitehawk Therapeutics Inc

Compare $IVVD vs $WHWK

Comparing Invivyd Inc and Whitehawk Therapeutics Inc

IVVDInvivyd Inc

WHWKWhitehawk Therapeutics Inc

IVVDInvivyd Inc

Market cap

$212M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.13x

Rev growth (TTM)

26.3%

YTD performance

-71.2%

52W performance

-56.0%

FCF yield

-51.6%

WHWKWhitehawk Therapeutics Inc

Market cap

$189M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

44.3%

52W performance

65.3%

FCF yield

-36.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IVVD

WHWK

Detailed metrics comparison

IVVD

Invivyd Inc

WHWK

Whitehawk Therapeutics Inc

Market Cap

IVVD$212M

WHWK$189M

Enterprise Value

IVVD$52M

WHWK$104M

Price

IVVD$0.72

WHWK$3.52

P/E Ratio

IVVDN/A

WHWKN/A

P/S Ratio

IVVD3.64x

WHWK7.56x

EV/Sales

IVVD0.90x

WHWK0.00x

EV/EBITDA

IVVD0.00x

WHWK0.00x

P/B Ratio

IVVD1.34x

WHWK1.15x

P/FCF Ratio

IVVDN/A

WHWKN/A

EV/FCF

IVVD-0.48x

WHWK-1.50x

PEG Ratio

IVVDN/A

WHWKN/A

Forward P/E (NTM)

IVVDN/A

WHWKN/A

Forward P/S (NTM)

IVVD3.13x

WHWKN/A

Revenue (TTM)

IVVD$58M

WHWK$0

Revenue Growth (YoY)

IVVD26.3%

WHWK-100.0%

Forward Rev Growth

IVVD44.8%

WHWK167.6%

Gross Margin (TTM)

IVVD92.2%

WHWK88.7%

Operating Margin (TTM)

IVVD0.0%

WHWK87.4%

EBITDA Margin (TTM)

IVVD-191.7%

WHWK0.0%

Net Margin (TTM)

IVVD-183.9%

WHWK99.4%

FCF Margin (TTM)

IVVD-187.9%

WHWKN/A

Net Income (TTM)

IVVD$-107M

WHWK$-80M

FCF (TTM)

IVVD$-110M

WHWK$-69M

EPS (TTM)

IVVD-$0.33

WHWK-$0.96

ROE (TTM)

IVVD-5973.0%

WHWK-5389.0%

ROA (TTM)

IVVD-4897.0%

WHWK-4997.0%

ROIC (TTM)

IVVD-5973.0%

WHWK-5389.0%

Cash

IVVD$160M

WHWK$85M

Debt

IVVD$0

WHWK$0

Net Cash/Debt

IVVD$160M

WHWK$85M

Current Ratio (TTM)

IVVD5.87x

WHWK17.38x

Quick Ratio (TTM)

IVVD5.60x

WHWK17.16x

Debt/Equity (TTM)

IVVD0.00x

WHWK0.00x

Debt/Assets (TTM)

IVVD0.0%

WHWK0.0%

Interest Coverage (TTM)

IVVDN/A

WHWKN/A

Net Debt/EBITDA (TTM)

IVVD0.00x

WHWK0.00x

Beta

IVVD1.32

WHWK0.99

52W Performance

IVVD-56.0%

WHWK65.3%

YTD Performance

IVVD-71.2%

WHWK44.3%

% from 52W High

IVVD-76.5%

WHWK-35.9%

% from 52W Low

IVVD36.7%

WHWK88.2%

Asset Turnover (TTM)

IVVD0.27x

WHWK0.23x

FCF Yield (TTM)

IVVD-51.6%

WHWK-36.6%

Earnings Yield (TTM)

IVVD-50.5%

WHWK-42.2%

Dividend Yield (TTM)

IVVDN/A

WHWKN/A

Rule of 40

IVVD-161.6

WHWK-100.0

EV/GP/RG

IVVD0.06

WHWKN/A

Ticker research

View IVVD research View WHWK research

Metric	IVVD Invivyd Inc	WHWK Whitehawk Therapeutics Inc
Market & Valuation
Market Cap	$212M	$189M
Enterprise Value	$52M	$104M
Price	$0.72	$3.52
P/E Ratio	N/A	N/A
P/S Ratio	3.64x	7.56x
EV/Sales	0.90x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.34x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.48x	-1.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.13x	N/A
Revenue & Growth
Revenue (TTM)	$58M	$0
Revenue Growth (YoY)	26.3%	-100.0%
Forward Rev Growth	44.8%	167.6%
Profitability
Gross Margin (TTM)	92.2%	88.7%
Operating Margin (TTM)	0.0%	87.4%
EBITDA Margin (TTM)	-191.7%	0.0%
Net Margin (TTM)	-183.9%	99.4%
FCF Margin (TTM)	-187.9%	N/A
Net Income (TTM)	$-107M	$-80M
FCF (TTM)	$-110M	$-69M
EPS (TTM)	-$0.33	-$0.96
ROE (TTM)	-5973.0%	-5389.0%
ROA (TTM)	-4897.0%	-4997.0%
ROIC (TTM)	-5973.0%	-5389.0%
Financial Health
Cash	$160M	$85M
Debt	$0	$0
Net Cash/Debt	$160M	$85M
Current Ratio (TTM)	5.87x	17.38x
Quick Ratio (TTM)	5.60x	17.16x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.32	0.99
52W Performance	-56.0%	65.3%
YTD Performance	-71.2%	44.3%
% from 52W High	-76.5%	-35.9%
% from 52W Low	36.7%	88.2%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.23x
FCF Yield (TTM)	-51.6%	-36.6%
Earnings Yield (TTM)	-50.5%	-42.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-161.6	-100.0
EV/GP/RG	0.06	N/A
Ticker research	View IVVD research	View WHWK research

Valuation

P/S Ratio

IVVD

3.64x

WHWK

7.56x

EV/FCF

WHWK

-1.50x

IVVD

-0.48x

Growth & revenue

Revenue Growth TTM

IVVD

26.3%

WHWK

-100.0%

Forward Revenue Growth

WHWK

167.6%

IVVD

44.8%

Profitability & performance

Gross Margin

IVVD

92.2%

WHWK

88.7%

ROE

WHWK

-5389.0%

IVVD

-5973.0%

FCF Yield %

WHWK

-36.6%

IVVD

-51.6%

52-Week Performance

WHWK

65.3%

IVVD

-56.0%

Detailed metrics comparison

IVVD

Invivyd Inc

WHWK

Whitehawk Therapeutics Inc

Market Cap

IVVD$212M

WHWK$189M

Enterprise Value

IVVD$52M

WHWK$104M

Price

IVVD$0.72

WHWK$3.52

P/E Ratio

IVVDN/A

WHWKN/A

P/S Ratio

IVVD3.64x

WHWK7.56x

EV/Sales

IVVD0.90x

WHWK0.00x

EV/EBITDA

IVVD0.00x

WHWK0.00x

P/B Ratio

IVVD1.34x

WHWK1.15x

P/FCF Ratio

IVVDN/A

WHWKN/A

EV/FCF

IVVD-0.48x

WHWK-1.50x

PEG Ratio

IVVDN/A

WHWKN/A

Forward P/E (NTM)

IVVDN/A

WHWKN/A

Forward P/S (NTM)

IVVD3.13x

WHWKN/A

Revenue (TTM)

IVVD$58M

WHWK$0

Revenue Growth (YoY)

IVVD26.3%

WHWK-100.0%

Forward Rev Growth

IVVD44.8%

WHWK167.6%

Gross Margin (TTM)

IVVD92.2%

WHWK88.7%

Operating Margin (TTM)

IVVD0.0%

WHWK87.4%

EBITDA Margin (TTM)

IVVD-191.7%

WHWK0.0%

Net Margin (TTM)

IVVD-183.9%

WHWK99.4%

FCF Margin (TTM)

IVVD-187.9%

WHWKN/A

Net Income (TTM)

IVVD$-107M

WHWK$-80M

FCF (TTM)

IVVD$-110M

WHWK$-69M

EPS (TTM)

IVVD-$0.33

WHWK-$0.96

ROE (TTM)

IVVD-5973.0%

WHWK-5389.0%

ROA (TTM)

IVVD-4897.0%

WHWK-4997.0%

ROIC (TTM)

IVVD-5973.0%

WHWK-5389.0%

Cash

IVVD$160M

WHWK$85M

Debt

IVVD$0

WHWK$0

Net Cash/Debt

IVVD$160M

WHWK$85M

Current Ratio (TTM)

IVVD5.87x

WHWK17.38x

Quick Ratio (TTM)

IVVD5.60x

WHWK17.16x

Debt/Equity (TTM)

IVVD0.00x

WHWK0.00x

Debt/Assets (TTM)

IVVD0.0%

WHWK0.0%

Interest Coverage (TTM)

IVVDN/A

WHWKN/A

Net Debt/EBITDA (TTM)

IVVD0.00x

WHWK0.00x

Beta

IVVD1.32

WHWK0.99

52W Performance

IVVD-56.0%

WHWK65.3%

YTD Performance

IVVD-71.2%

WHWK44.3%

% from 52W High

IVVD-76.5%

WHWK-35.9%

% from 52W Low

IVVD36.7%

WHWK88.2%

Asset Turnover (TTM)

IVVD0.27x

WHWK0.23x

FCF Yield (TTM)

IVVD-51.6%

WHWK-36.6%

Earnings Yield (TTM)

IVVD-50.5%

WHWK-42.2%

Dividend Yield (TTM)

IVVDN/A

WHWKN/A

Rule of 40

IVVD-161.6

WHWK-100.0

EV/GP/RG

IVVD0.06

WHWKN/A

Ticker research

View IVVD research View WHWK research

Metric	IVVD Invivyd Inc	WHWK Whitehawk Therapeutics Inc
Market & Valuation
Market Cap	$212M	$189M
Enterprise Value	$52M	$104M
Price	$0.72	$3.52
P/E Ratio	N/A	N/A
P/S Ratio	3.64x	7.56x
EV/Sales	0.90x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.34x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.48x	-1.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.13x	N/A
Revenue & Growth
Revenue (TTM)	$58M	$0
Revenue Growth (YoY)	26.3%	-100.0%
Forward Rev Growth	44.8%	167.6%
Profitability
Gross Margin (TTM)	92.2%	88.7%
Operating Margin (TTM)	0.0%	87.4%
EBITDA Margin (TTM)	-191.7%	0.0%
Net Margin (TTM)	-183.9%	99.4%
FCF Margin (TTM)	-187.9%	N/A
Net Income (TTM)	$-107M	$-80M
FCF (TTM)	$-110M	$-69M
EPS (TTM)	-$0.33	-$0.96
ROE (TTM)	-5973.0%	-5389.0%
ROA (TTM)	-4897.0%	-4997.0%
ROIC (TTM)	-5973.0%	-5389.0%
Financial Health
Cash	$160M	$85M
Debt	$0	$0
Net Cash/Debt	$160M	$85M
Current Ratio (TTM)	5.87x	17.38x
Quick Ratio (TTM)	5.60x	17.16x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.32	0.99
52W Performance	-56.0%	65.3%
YTD Performance	-71.2%	44.3%
% from 52W High	-76.5%	-35.9%
% from 52W Low	36.7%	88.2%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.23x
FCF Yield (TTM)	-51.6%	-36.6%
Earnings Yield (TTM)	-50.5%	-42.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-161.6	-100.0
EV/GP/RG	0.06	N/A
Ticker research	View IVVD research	View WHWK research